Summit faculty members Jeffery S. Berger, MD, MS, Assistant Professor of Medicine, New York University School of Medicine; and James de Lemos, MD, Professor of Medicine, University of Texas Southwestern...
Michael Banks, MD, discusses factors associated with hyper-progression and super-responders among cancer patients, which could help identify those most likely to benefit from immunotherapy.
In this video, Vibeke Strand, MD, highlights current JAK inhibitors for the treatment of immune-mediated inflammatory diseases, how they may be used in the future, and more.
Bankole A. Johnson, DSc, MD, of the University of Maryland School of Medicine, discusses a new treatment option on the horizon for alcohol use disorder.
In this video, Cindy Cooke, DNP, gives a preview of a new session type at our Practical Updates in Primary Care 2021 Virtual Series, in which the co-chairs present challenging case studies and discuss the...
